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Aim of the work: Investigating the utility, sensitivity and speciﬁcity of interferon gamma induc-
ible protein IP-10 in both blood and bronchoalveolar lavage (BAL) in the diagnosis of TB infection
in clinically suspected patients.
Methods: Thirty patients with clinical and/or radiological suspicion of pulmonary tuberculosis
and negative sputum smear for AFB with Z–N stain were included in the study. BAL and blood
samples were sent for the estimation of the level of interferon gamma inducible protein IP-10.
Results: IP-10 levels in both blood and BAL were signiﬁcantly higher in TB patients (P= 0.005
and 0.007 respectively). Sensitivity of IP-10 in blood was 100% and speciﬁcity was 60%. Positive
predictive value was 56%, negative predictive value was 100% and accuracy was 73%. Sensitivity
of IP-10 in BAL was 100% and speciﬁcity was 35%. Positive predictive value was 44%, negative
predictive value was 100% and accuracy was 57%. Sensitivity of IP-10 in blood and BAL were sim-
ilar (100%) and both were more sensitive than tuberculin skin test (TST) (sensitivity 67%). Detec-
tion of IP-10 in blood (speciﬁcity = 60%) was more speciﬁc than its detection in BAL
(speciﬁcity = 35%). On the other hand, speciﬁcity of detection of IP-10 in blood (60%) was com-
parable to the tuberculin test (speciﬁcity = 62%).est Department, Menouﬁya
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infection and monitoring disease activity and efﬁcacy of therapy.
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Tuberculosis (TB) remains the infectious disease causing the
highest mortality in humans, leading to 3 million deaths annu-
ally [1].
Control of this disease depends largely on early detection
and treatment of active cases. Smear microscopy and nucleic
acid ampliﬁcation test are the two currently available rapid
conﬁrmatory tests for active TB disease diagnosis, but both
are limited by their poor sensitivity. Culturing the mycobacte-
rium, requires several weeks to obtain the results [2,3].
Interferon gamma release assays (IGRA), in which the pro-
duction of interferon gamma (IFN-c) in response to Mycobac-
terium Tuberculosis speciﬁc antigens is measured, are starting
to get popularity. IFN-c inducible protein (IP)-10 is a potential
biomarker for TB diagnosis [4,5]. IP-10 is a pro-inﬂammatory
chemokine, expressed by monocytes and macrophages upon
contact with viral or bacterial agents [6].
Aim of the work
In this study, we aim at investigating the utility as well as sen-
sitivity and speciﬁcity of interferon gamma inducible protein
IP-10, in both blood and bronchoalveolar lavage (BAL), in
the diagnosis of TB infection in clinically suspected patients.
Methods
Thirty patients with clinical and/or radiological suspicion of
pulmonary tuberculosis and negative sputum smear for AFB
with Z–N stain were included in the study. All patients were
admitted in the Chest Department; Menouﬁya University Hos-
pitals from January 2010 to March 2012.
An informed consent was taken from all patients who were
subjected to the following:
 Blood samples were sent for the estimation of the level of
interferon gamma inducible protein IP-10.QFT-IP-10 assay
The IP-10 levels were measured in duplicates in the superna-
tants collected from QFT-IT tubes using BD (BD Biosciences,
USA) EIA kits. Brieﬂy, 100 ml of capture antibody (mouse
anti human IP-10 monoclonal antibody) at the recommended
concentration was coated in the 96-well ﬂat bottom polysty-
rene plates (NUNC maxisorp, Roskilde, Denmark). After
overnight incubation, the excess antibodies were washed off
using PBST. The sample was added to the plate, incubated
for 2 h and then the plates were washed off. The secondary
antibody (biotinylated anti human IP-10 monoclonal anti-
body) conjugated with HRP was incubated for 1 h and thenthe excess antibodies were washed off. Then tetra methyl ben-
zidine (TMB) was used as substrate and incubated for 30 min
and the reaction was arrested by the addition of 2 N H2SO4.
Fiber-optic bronchoscopy (FOB)
FOB was done (using Pentax FB, 19-TV, with internal diame-
ter of 2 mm) for all patients and bronchoalveolar lavage was
sent for Ziehl–Nelsen (Z–N) stain and for estimation of the le-
vel of interferon gamma inducible protein 10 (IP-10) in similar
steps to evaluate the level.
Tuberculin skin test (TST)
Tuberculin test was done in 19 out of 30 patients only. The 2
TU (tuberculin unit) of puriﬁed protein derivative (PPD) were
injected intradermally by Mantoux method and the induration
was measured between 48–72 h after PPD injection by trained
personnel. An induration of P5 mm was considered positive.
Statistical analysis
Data were processed and analyzed using a computer based
program (SPSS software version 10). The results were ex-
pressed as range, mean and standard deviation. For compari-
son of two means, Student t-test was used. A P-value <0.05
was considered signiﬁcant. Sensitivity and speciﬁcity of IP-10
estimation in blood and BAL and tuberculin test were calcu-
lated in comparison with detection of TB in BAL by Z–N
stain. Sensitivity is a true positive rate (positive in disease i.e.
how good is this test at picking up people who have the condi-
tion). Speciﬁcity is true negative rate (negative in health i.e.
how good is this test at correctly excluding people without
the condition). Positive predictive value is post-test probability
of positive test i.e. if a person’s test is positive, what is the
probability that he has the condition. Negative predictive value
is post-test probability of a negative test i.e. if a person’s test is
negative, what is the probability that he does not have the con-
dition. Accuracy i.e. what proportion of all tests has given the
correct result? (true positive and true negative as a proportion
of all results).
Results
Table 1 shows IP-10 levels in blood and BAL in patients with
and without TB according to detection of TB in BAL. Ten out
of 30 patients were proved to have TB by BAL. IP-10 levels in
blood were signiﬁcantly higher in TB patients (P= 0.005).
Also, IP-10 levels in BAL were signiﬁcantly higher in TB pa-
tients (P= 0.007) (Table 1, Fig. 1).
IP-10 in blood was positive in 18 out of 30 patients. Ten of
them were proved positive by detection of TB in BAL, and 8
were false positive. Twelve patients are true negative. No false
negative patient was detected by IP-10 in blood.
Table 1 IP-10 levels in blood and BAL in patients with and without TB according to detection of TB in BAL (mean ± SD).
Patients with TB Patients without TB P-value
(n= 10) (n= 20)
IP-10 in blood (pg/ml) 535 ± 123.1 336.3 ± 177.1 0.005*
Range 350–700 190–730
IP-10 in BAL (pg/ml) 1011 ± 289.2 570 ± 414.9 0.007*
Range 600–1450 240–1550
Figure 1 Comparison between level of quantiferone IP-10 in blood and BAL in patients with and without TB.
Figure 2 Comparison of sensitivity of IP-10 in blood and BAL
and tuberculin test in patients with and without TB.
Figure 3 Comparison of speciﬁcity of IP-10 in blood and BAL
and tuberculin test in patients with and without TB.
Utility of IP-10 level inthe diagnosis of tuberculosis 631Sensitivity of IP-10 in blood was 100% (Fig. 2) and speci-
ﬁcity was 60% (Fig. 3). Positive predictive value was 56%,
negative predictive value was 100% and accuracy was 73%
(Table 2) (Fig. 4).
IP-10 in BAL was positive in 23 out of 30 patients. Ten of
them were proved positive by detection of TB in BAL, and 13
were false positive. Seven patients were true negative. No false
negative patient was detected by IP-10 in BAL.
Sensitivity of IP-10 in BAL was 100% (Fig. 2) and speciﬁc-
ity was 35% (Fig. 3). Positive predictive value was 44%, neg-
ative predictive value was 100% and accuracy was 57% (Table
2) (Fig. 4).
Tuberculin test was done in 19 out of 30 patients only and
was positive in 9 of them. Four out of 9 positive patients bytuberculin were proved positive by detection of TB in BAL,
and 5 were false positive. Eight patients were true negative
and 2 patients were false negative. Therefore TB was detected
in BAL in 6 patients out of 19 patients who underwent tuber-
culin test. Sensitivity of tuberculin test was 67% (Fig. 2) and
speciﬁcity was 62% (Fig. 3). Positive predictive value was
44%, negative predictive value was 80% and accuracy was
63% (Table 2) (Fig. 4).
Sensitivity of IP-10 in blood and BAL were similar (100%)
and both were more sensitive than tuberculin test (sensitivity
67%) (Table 2) (Fig. 2). Detection of IP-10 in blood (speciﬁc-
ity = 60%) was more speciﬁc than its detection in BAL (spec-
iﬁcity = 35%) (Table 2) (Fig. 3). On the other hand, speciﬁcity
of detection of IP-10 in blood (60%) was comparable to tuber-
culin test (speciﬁcity = 62%) (Table 2) (Fig. 3).
Table 2 Comparison of sensitivity, speciﬁcity, positive and negative predictive values and accuracy of IP-10 in blood and BAL and
tuberculin test.
Sensitivity Speciﬁcity Accuracy Positive predictive value Negative predictive value
IP-10 in blood (pg/ml), 100% 60% 73% 56% 100%
IP-10 in BAL (pg/ml) 100% 35% 57% 44% 100%
Tuberculin test 67% 62% 63% 44% 80%
Figure 4 Comparison of accuracy of IP-10 in blood and BAL and tuberculin test in patients with and without TB.
632 N.Y. Azab et al.Detection of IP-10 in blood (accuracy = 73%) was more
accurate than its detection in BAL (accuracy = 57%) and than
in tuberculin test (accuracy = 63%) (Table 2) (Fig. 4).
Accuracy of detection of IP-10 in blood (73%) was compara-
ble to detection of TB in BAL (72%) (Table 2) (Fig. 4).
Discussion
Most people infected with M. tuberculosis remain asymptom-
atic, latent TB, with a 10% lifetime risk of developing active
disease. Current tests, however, cannot identify which individ-
uals will develop the disease. The immune response to M.
tuberculosis is complex, stimulating the development of new
diagnostics, therapies and vaccines [7].
Following the infection with Mycobacterium tuberculosis,
host cytokine responses inﬂuence disease manifestation. Dif-
ferences in cytokine expression determine whether tuberculosis
(TB) will progress, resolve, or become latent. The balance be-
tween Th (1) and Th (2) cytokine responses inﬂuences the
expression of the disease. Increased IFN gamma, IL-12, IP-
10, and TGF beta are found in granulomas and in pneumonitis
areas of the TB lungs. This link involves many mechanisms,
some remain obscure and others are recently clariﬁed [8].
The production of nitric oxide and inﬂammatory cytokines
controls intracellular replication of M. tuberculosis. Inducible
nitric oxide synthase (iNOS) is transcriptionally under the con-
trol of IFN-gamma and TNF-alpha. IL-12 provides a crucial
link between activated mononuclear phagocytes and T cells
by regulating the production of IFN-gamma. Infected mono-
cytes from newly diagnosed TB patients produced signiﬁcantly
higher levels of NO as compared to those from normal con-
trols [9].
In this study, we aimed at investigating the utility as well as
sensitivity and speciﬁcity of interferon gamma inducible
protein IP-10, in both blood and bronchoalveolar lavage(BAL), in the diagnosis of TB infection in clinically suspected
patients. IP-10 levels in both blood and BAL were signiﬁcantly
higher in TB patients (P= 0.005 and 0.007 respectively).
Chen et al. stated that IP-10 may be used for detecting LTBI
and as a potential biomarker to identify active TB [10].This
was described independently of age [11,12] and even in house-
hold contacts [13]. Sensitivity of IP-10 in blood was 100%
(Fig. 2) and speciﬁcity was 60% (Fig. 3). Positive predictive
value was 56%, negative predictive value was 100% and accu-
racy was 73% (Table 2) (Fig. 4). Sensitivity of IP-10 in BAL
was 100% (Fig. 2) and speciﬁcity was 35% (Fig. 3). Positive
predictive value was 44%, negative predictive value was
100% and accuracy was 57%.
Local increases of immune responses were expected andwere
reported in pleural ﬂuid from the TBpatients [14]. The increased
level was facilitated by resident memory cells of the lung of pre-
viously infected persons. This IFN-gamma production is pre-
dominantly a function of CD4+ T cells that display the
CD45RO+/CCR7 surface phenotype characteristic of effec-
tor memory cells [15]. Raju et al. reported the genetic bases of
this immune function by retrieving higher IP-10 mRNA in
BAL cells from TB patients [16].
Ruhwald et al. found that the speciﬁcity of IP-10 was
48%and it yielded a diagnostic sensitivity of 92.5% compared
to TST which had a sensitivity of 73.9% [17]. The variable
speciﬁcity and sensitivity [18] were not expected since the cur-
rently available data suggest that IP-10 is less inﬂuenced by
prior BCG vaccination and environmental mycobacteria [19].
The severity and extent of the disease might be a cause or
consequence of this variability since non-cavitary TB had
signiﬁcantly higher BAL interferon gamma-inducible protein
(IP-10) and interleukin (IL)-7 than those with cavities [20].
Serum IP-10 after 2 months of anti-TB treatment may be a
predictor of monitoring therapy efﬁcacy and long-term
mortality [21,22]. False positive results for BAL levels of IP-
Utility of IP-10 level inthe diagnosis of tuberculosis 63310 are reported in respiratory viral infection where sequential
BAL ﬂuids from all patients hospitalized with acute respira-
tory illness revealed showed high levels of IP-10 [23].
Also, the same increased levels where reported in patients
with sarcoidosis and in IPF patients because lung ﬁbroblasts
are polarized to produce Th1 chemokines involving
predominant induction of IP-10 [24]. But the levels were signif-
icantly higher in sarcoidosis patients compared with IPF pa-
tients [25].
Sensitivity of tuberculin test was 67% and speciﬁcity was
62%. Positive predictive value was 44%, negative predictive
value was 80% and accuracy was 63%. Speciﬁcity is decreased
since TST positivity is inﬂuenced by prior BCG vaccination
[19]. Kabeer et al. reported that there was no signiﬁcant differ-
ence observed between TST and IP-10 results regardless of the
demographic proﬁle and/or severity of TB [26].
TST positivity was reported to be even signiﬁcantly lower
when compared to IP-10 in HIV patients in whom indetermi-
nate results for IP-10 were more frequent in subjects with CD4
count <100 cells/lL [27]. This study showed that BAL IP-10
levels offered no more beneﬁt over its blood levels and are
not advised as routine or a discriminating tool in conﬁrming
TB diagnosis.
We can deduce that IP-10, a chemokine involved in de-
layed-type hypersensitivity and attraction of monocytes and
activated T-lymphocytes at inﬂammatory foci, although not
speciﬁc for TB, may help enhancing the diagnostic perfor-
mance of IGRAs in detecting M. tuberculosis infection and
monitoring disease activity and efﬁcacy of therapy [28].
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